Transdermal Diagnosis of Malaria Using Vapor Nanobubbles. by Lukianova-Hleb, Ekaterina et al.
Lukianova-Hleb, Ekaterina; Bezek, Sarah; Szigeti, Reka; Khodarev,
Alexander; Kelley, Thomas; Hurrell, Andrew; Berba, Michail; Ku-
mar, Nirbhay; D’Alessandro, Umberto; Lapotko, Dmitri (2015) Trans-
dermal Diagnosis of Malaria Using Vapor Nanobubbles. EMERGING
INFECTIOUS DISEASES, 21 (7). pp. 1122-1127. ISSN 1080-6040
DOI: https://doi.org/10.3201/eid2107.150089
Downloaded from: http://researchonline.lshtm.ac.uk/4651688/
DOI: 10.3201/eid2107.150089
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
A	 fast,	 precise,	 noninvasive,	 high-throughput,	 and	 simple	
approach	for	detecting	malaria	in	humans	and	mosquitoes	
is	not	possible	with	current	techniques	that	depend	on	blood	
sampling,	 reagents,	 facilities,	 tedious	 procedures,	 and	
trained	personnel.	We	designed	a	device	for	rapid	(20-sec-
ond)	 noninvasive	 diagnosis	 of	Plasmodium falciparum in-
fection	in	a	malaria	patient	without	drawing	blood	or	using	
any	reagent.	This	method	uses	transdermal	optical	excita-
tion	 and	acoustic	 detection	 of	 vapor	 nanobubbles	 around	
intraparasite	hemozoin.	The	same	device	also	identified	in-
dividual	malaria	parasite–infected	Anopheles mosquitoes in 
a	few	seconds	and	can	be	realized	as	a	low-cost	universal	
tool	for	clinical	and	field	diagnoses.
Malaria control and elimination would benefit greatly from an efficient and universal diagnostic tool that 
is fast (provides results in seconds), noninvasive and safe 
(uses no blood sampling or reagents), simple to use (can be 
operated by nonmedical personnel), sensitive and specific 
(detects low-level asymptomatic infections), and inexpen-
sive and that detects malarial infection in humans and in 
mosquitoes (1–21). We recently proposed a transdermal 
blood- and reagent-free approach based on hemozoin-gen-
erated vapor nanobubbles (H-VNBs) (22) in which malaria 
parasite–specific endogenous nanocrystals of hemozoin are 
optically excited in vivo with a safe and short laser pulse 
(delivered to blood vessels through the skin). The light is 
converted into nonstationary localized heat that evaporates 
the adjacent nanovolume of liquid and thus generates an 
expanding and collapsing vapor nanobubble inside the par-
asite. The nanosize and high optical absorbance of hemo-
zoin provide higher malaria infection specificity of these 
H-VNBs than does any normal blood and tissue components 
(23–26). Their transient expansion and collapse result in a 
noninvasive pressure pulse that is easily detected through 
the skin with an ultrasound sensor. In our preliminary stud-
ies (22), H-VNBs detected parasitemia as low as 0.0001% 
in vitro (human blood), and 0.00034% in vivo (transder-
mal detection in animals), with no false-positive signals. 
Therefore, H-VNB might be able to detect extremely low 
parasite densities provided the method can be applied to 
humans or mosquitoes simply and inexpensively.
To determine the technical and medical feasibility of 
H-VNBs for malaria diagnosis and screening, we proto-
typed a diagnostic device and evaluated it in a patient with 
confirmed malaria and in noninfected persons as controls. 
We also evaluated the device in Plasmodium falciparum–
infected mosquitoes.
Materials and Methods
Prototype Design and Algorithms
The laboratory prototype (Figure 1, panel A) comprised 
the newly designed compact low-cost pulsed laser (532 
nm, 10 μJ, 200 ps; Standa, Vilnius, Lithuania). The laser 
pulse is delivered to the skin by the combination probe 
at the fluence 36 mJ/cm2 (Figure 1, panel B). The probe 
was developed for transdermal diagnostics and includes 
an optical fiber guide and a custom acoustic sensor with 
a preamplifier that is integrated in 1 compact hand-held 
unit. In response to each laser pulse, the probe detects an 
acoustic pulse and generates an output electrical signal as 
an acoustic trace (Figure 1). Its output signals were col-
lected and analyzed with custom-designed software (NI 
LabVIEW, Austin, TX, USA) by using a signal amplifier, 
digital oscilloscope (LeCroy 42X; Teledyne LeCroy, NY, 
USA), and computer. The peak-to-peak amplitude A of the 
acoustic trace obtained in response to each laser pulse was 
measured and presented as a histogram for 400 sequential 
laser pulses. A malarial infection–negative trace histogram 
was used to determine “the malaria threshold” T as the 
maximum amplitude for the malarial infection–negative 
signal. Any trace with an amplitude above that threshold 
was considered to be hemozoin (malarial infection)–posi-
tive. To quantify the infection, we counted the incidence 
rate of malarial infection–positive traces IR (the probability 
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of the trace incidence with an amplitude above the malaria 
threshold calculated for 400 laser pulses) and calculated the 
Hemozoin Index (HI) (22): HI = IR(A – T).
Monitoring of Transient Vapor Nanobubbles
The direct monitoring of transient vapor nanobubbles in 
response to a single laser pulse uses our optical scatter-
ing method (27,28). This method used time-resolved op-
tical scattering of a probe continuous laser beam of very 
low power (633 nm, 0.1 mW). The probe laser beam was 
focused on the blood sample collinearly with the excita-
tion laser pulse. The axial intensity of the probe laser beam 
that passed through the blood sample was monitored with 
a photodetector. The response to the laser pulse included 
bulk heating and generation of a transient vapor nanobub-
ble. The bulk heating of the exposed blood volume (with-
out generation of a vapor nanobubble) was detected opti-
cally by using a thermal lensing effect that revealed the fast 
heating and gradual cooling of the exposed volume (Figure 
2, panel A, black line in inset). The generation of an ex-
panding and collapsing vapor nanobubble created a strong 
localized scattering of the probe laser beam by the vapor–
liquid boundary, and this effect reduced the probe beam 
intensity with the bubble diameter (Figure 2, panel A, red 
line in inset). A vapor nanobubble–specific signal typically 
is shaped like an inverted bell and represents the growth 
and collapse of the bubble.
Patient with Confirmed Malaria
The patient was admitted to Ben Taub General Hospital, 
Harris Health System (Houston, TX, USA), with fever, 
myalgia, abdominal pain, nausea, and vomiting for the 
previous 4 days and no history of malaria chemoprophy-
laxis. Malaria identification and speciation was done by mi-
croscopy (thin, Wright-Giemsa–stained, peripheral blood 
smears) and a rapid malaria antigen test (BinaxNow Malar-
ia; Alere Scarborough, Inc., Scarborough, ME, USA). Both 
tests confirmed a P. falciparum malaria infection. By the 
time of the H-VNB test, the patient had already received 
antimalarial drugs (doxycycline, malarone, quinidine, and 
quinine) for 24 h. During hospitalization, the patient had 
mild hemolytic anemia and thrombocytopenia, neither of 
which required transfusion of blood products. In addition 
to the antimalarial medications and to provide symptomatic 
relief, the patient received intravenous fluids, antiemetics, 
and antipyretics.
Diagnostic Locations
We found wrist and ear lobe veins to be the optimal lo-
cation for the test. Fingertips were also explored but were 
inadequate because some persons develop very thick and 
rigid skin patterns that prevent efficient transdermal deliv-
ery of a laser pulse to the blood vessels.
Influence of Skin Tone
The difference between the amplitudes of the in vitro back-
ground traces from intact blood (Figure 2, panel B, black 
bars) and those in vivo from a malaria-negative volunteer 
(Figure 2, panel D, black bars) accounts for the additional 
contribution of the optical absorbance by melanin in dark 
skin. The increase in the bulk optical absorbance conse-
quently increased the bulk transient heating (without the 
generation of H-VNBs) and thus increased the average 
trace amplitude of the background trace from 10.7 ± 1.7 
mV in blood alone (in vitro) to 18.1 ± 5.4 mV in blood 
and skin (in human) as can be seen by comparing the black 
histograms in Figure 2, panels B and D. We further stud-
ied the influence of skin tone on the background trace in 
5 healthy volunteers with different skin tones (Figure 2, 
panel F). For 532-nm wavelength light, the predictable in-
crease in the background trace amplitude resulted from the 
higher concentration of the skin pigment, melanin, which 
determines skin darkness (tone). Therefore, in malaria di-
agnosis, reference malaria-negative data (histogram and 
threshold) should be linked to the same level of skin tone 
as in the malaria patient. Although the optical absorbance 
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Figure 1. A)	Experimental	
laboratory	prototype	of	a	malaria	
diagnostic	device	with	the	pulsed	
laser	and	the	integrated	probe	
shown	being	scanned	across	
a	human	wrist.	B)	Functional	
diagram	of	the	prototype	and	the	
principle	of	transdermal	optical	
excitation	and	acoustic	detection	
of	vapor	nanobubbles	around	
hemozoin	in	malaria-infected	
cells	exposed	to	the	laser	
pulses	(green	arrows).	H-VNB,	
hemozoin-generated	vapor	
nanobubble.
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of skin pigment and hemoglobin is not as high as that for 
hemozoin (23,24) and is not sufficient to generate vapor 
nanobubbles under the laser pulse duration and fluence 
used (29), the bulk transient heat released by hemoglobin 
and melanin generates a background acoustic trace, which 
limits the signal-to-noise ratio for the H-VNB method and 
thus increases the detection threshold for malaria infec-
tion. This limitation will be alleviated by developing a 
“malaria-specific” pulsed laser with a wavelength ≈672 
nm—the focus of our ongoing effort because such lasers 
are not currently available. The optical absorbance of he-
moglobin and melanin at 672 nm is much lower than that at 
532 nm, and the amplitudes of the background signals and 
their dependence on skin tone will be reduced. At the same 
time, the laser pulse energy efficacy of H-VNB generation 
at 672 nm is similar to that at 532 nm, as we demonstrated 
previously (22).
Mosquito Model
For infection in mosquitos, female Anopheles gambiae 
mosquitoes were fasted for 6 hours and fed on infected 
blood by using jacketed membrane feeders warmed to 
37°C by a circulating water bath. Briefly, cultured P. fal-
ciparum (NF54 strain) gametocytes were diluted to 0.3% 
gametocytemia, 50% normal human erythrocytes and hu-
man serum for 15 min. After removing unfed mosquitoes, 
blood-fed mosquitoes were maintained at 26°C and 
70%–80% relative humidity on 10% dextrose. Ten days 
later, 15 randomly selected mosquitoes were dissected to 
determine the oocyst numbers, and 2 other groups were 
used for the device evaluation. Midguts were stained 
with 0.1% mercurochrome and oocysts counted micro-
scopically. Each of the 15 mosquitoes had 9–151 oocysts 
(median 50). The remaining mosquitoes were killed by 
freezing at -20°C before analysis using the prototype de-
vice. Mosquitoes fed on uninfected blood and maintained 
as described were used as negative controls (uninfected 
and oocyst negative). For further use as positive controls, 
mosquitoes were fed on uninfected blood containing 60 
μg/mL hemozoin.
All procedures were approved by the corresponding 
internal review board committees at Rice University and 
Baylor College of Medicine (for Ben Taub Hospital). The 
patient and the volunteers provided informed consent.
Results and Discussion
We have prototyped a diagnostic device (Figure 1) and 
evaluated it in a malaria patient and uninfected controls 
and in malaria infection–positive mosquitoes. Initial in 
vitro validation of the designed prototype used samples of 
whole human blood without (uninfected blood) and with 
hemozoin (#tlrl-hz; InvivoGen, San Diego, CA, USA) 
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Figure 2.	A)	Acoustic	traces	obtained	in	vitro	in	response	to	a	single	laser	pulse	exposure	(532	nm,	36	mJ/cm2	delivered	at	0	time	
point)	from	the	sample	of	whole	human	blood	(black)	and	for	the	same	blood	sample	after	the	addition	of	hemozoin	in	the	concentration	
corresponding	to	the	parasitemia	level	of	0.8%	(red).	y-axis	shows	the	output	signal	of	the	acoustic	sensor,	Inset:	optical	scattering	
time-responses	obtained	for	these	2	samples	show	the	transient	bulk	heating	of	the	blood	(black)	and	the	generation	of	transient	
vapor	nanobubble	(red).	B)	Histograms	of	the	trace	amplitudes	for	400	traces	obtained	under	identical	conditions	for	the	above	2	
samples.	y-axis	indicates	number	of	traces	with	the	amplitude	in	the	specific	range.	C)	Acoustic	traces	obtained	from	the	wrist	veins	
of	an	uninfected	volunteer	with	light	dark	skin	(black)	and	from	a	malaria-diagnosed	patient	with	light	dark	skin	(red).	D)	Histograms	
of	the	acoustic	trace	amplitudes	obtained	from	the	wrist	veins	of	an	uninfected	volunteer	with	light	dark	skin	(black)	and	for	a	malaria-
diagnosed	patient	with	similar	light	dark	skin	(red).	E)	Histograms	of	the	acoustic	trace	amplitudes	obtained	from	the	earlobes	of	an	
uninfected	volunteer	(black)	and	for	a	malaria-diagnosed	patient	(red).	F)	Histograms	of	the	acoustic	trace	amplitudes	obtained	for	
healthy	volunteers	with	different	skin	darkness:	green,	pale	light	skin;	black,	light	dark	skin;	blue,	dark	skin.	G)	Acoustic	traces	obtained	
transcuticle	from	individual	mosquitoes:	fed	with	uninfected	blood	and	oocyst	negative	(black)	and	fed	with	malaria-infected	blood	and	
oocyst	positive	(red).	H)	Histograms	of	the	acoustic	trace	amplitudes	obtained	from	oocyst-negative	(black)	and	oocyst-positive	(red)	
mosquitoes	and	mosquitoes	fed	with	uninfected	blood	mixed	with	hemozoin	at	60	μg/mL	(green).
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(a proxy for malaria parasite–infected blood [22]). The 
sample cuvette modeled the blood vessel by using a 
skin-colored film, a channel with blood 1 mm deep, and 
an acoustically dampening bottom. The bulk optical ab-
sorption of the laser pulse at 532 nm by normal whole 
blood (mainly by hemoglobin) produced the background 
trace (Figure 2, panel A, black line) associated with the 
thermo-elastic effect (30) (a heat-driven transient pressure 
rise). However, no vapor nanobubbles were generated be-
cause the laser fluence applied was well below the vapor 
nanobubble generation threshold for any normal blood 
components (22). The absence of vapor nanobubbles was 
confirmed experimentally by monitoring the laser pulse-
exposed sample volume with an optical scattering method 
(22,27) by using a low-power probe laser beam at 633 nm 
and monitoring its time-response to the excitation laser 
pulse (Figure 2, panel A, black line in inset). In normal 
blood, the optical scattering time-response to a single laser 
pulse indicated incremental transient bulk heating with-
out generating a vapor nanobubble. Previously we have 
shown that such a bulk photothermal effect does not cause 
any detectable detrimental effects at the molecular and 
cellular levels (22). Adding hemozoin nanocrystals to the 
blood at a concentration of 23 μg/mL, (which corresponds 
to ≈0.8% of parasitemia [9]), resulted in a completely dif-
ferent acoustic trace under the same excitation and detec-
tion conditions (Figure 2, panel A, red line). This trace 
was attributed to H-VNBs, which were directly detected 
in the same sample by optical scattering with optical time-
responses of 50–100 ns duration and the H-VNB-specific 
shape, which revealed the vapor bubble expansion and 
collapse without any recoil (Figure 2, panel A, red line 
in inset). Unlike the background acoustic traces obtained 
from the normal blood, the H-VNB acoustic traces yielded 
5-fold higher peak-to-peak amplitudes and thus were eas-
ily differentiated from the blood background traces in the 
trace amplitude histograms (Figure 2, panel B).
To obtain proof of the device feasibility, the prototype 
was further tested in human volunteers who did not have 
malaria and on a malaria patient with a similar skin tone 
(dark). We applied the probe to wrists and earlobes and 
positioned it over subcutaneous vessels. Thus, laser pulses 
were delivered to blood through the skin. No blood samples 
were taken, and no reagents were applied. Acoustic traces 
in response to each of 400 laser pulses (of the same flu-
ence as described earlier) were collected simultaneously 
with laser irradiation (within 20 seconds total) and ana-
lyzed statistically in real time. In the malaria patient, the 
parasitemia (percentage of infected erythrocytes) was de-
termined by microscopy (thin blood film) and varied from 
2% (corresponding to ≈69,000 parasites/μL) 4 hours before 
the device test to 0.3% (corresponding to ≈8,600 para-
sites/μL) 9 hours after the device test. As malaria-negative 
controls, we used healthy volunteers with similar skin 
tone and under the conditions and procedure applied to 
the malaria patient. Acoustic traces from the wrist of the 
malaria patient (Figure 2, panel C, red line) showed the H-
VNB–specific pattern similar to that of the hemozoin-pos-
itive samples in vitro (Figure 2, panel A, red line) and had 
much higher amplitudes than those obtained from a healthy 
volunteer with a similar skin tone (Figure 2, panel C, black 
line). The amplitudes for the traces from the malaria pa-
tient were significantly higher than those from the control, 
and the 2 histograms barely overlapped (Figure 2, panel D). 
Therefore, these acoustic traces indicated malarial infec-
tion in a clinically ill patient. Similar traces were obtained 
when the device was applied to the earlobes of the malaria 
patient and volunteers (3 volunteers with dark skin tone 
were studied) (Figure 2, panel E). The similarity between 
the wrist and ear lobe results further validates the success-
ful detection of malarial infection by the H-VNB method. 
A quantitative analysis used the volunteers’ histograms to 
determine the malaria threshold amplitude and revealed HI 
values as 42.4 mV and 1.3 mV in the malaria patient for the 
wrist and earlobe, respectively.
The safety of H-VNB generation in humans is ensured 
by the safe level of the laser fluence applied, 36 mJ/cm2, 
which is considered to be skin-safe according to federal 
regulations (31). In addition, no short-term (10 min) or 
long-term (3–4 d) signs of skin damage or irritation were 
observed in the study participants. These observations are 
also in line with our previous observation of no damage 
to the laser-exposed malaria parasite–negative blood cells 
(22). Therefore, the device and procedure developed ap-
pear to be safe, and coupled with their blood- and reagent-
free nature, deliver a completely noninvasive diagnosis of 
malaria in humans.
We further studied the influence of skin tone on the 
background trace for 5 healthy volunteers with different 
skin tones (Figure 2, panel F). For 532-nm wavelength 
light, we observed a predictable increase in the background 
trace amplitude resulting from the increase in the concen-
tration of melanin.
In the third model, we evaluated the device for the rap-
id noninvasive transcuticle analysis of individual malaria-
infected (oocyst-positive) Anopheles mosquitoes. Ten 
acoustic traces were obtained for each mosquito (7 in each 
group) by scanning the body across the probe under the 
same laser pulse fluence as described for the human stud-
ies. The negative control group (fed with uninfected hu-
man blood, no oocysts) returned acoustic traces similar to 
those for hemozoin- and malaria parasite–negative human 
blood (Figure 2, panel G, black line). In the malaria-infect-
ed mosquitoes, the trace shape and amplitude (Figure 2, 
panel G, red line) were similar to those obtained for hemo-
zoin- and malaria parasite–positive traces. The histogram 
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of malaria-infected mosquitoes significantly shifted to the 
right, compared with the negative control group (Figure 
2, panel H). Finally, the positive control group of mosqui-
toes fed with the blood mixed with hemozoin (60 μg/mL) 
also showed traces of a high amplitude (Figure 2, panel H, 
green bars). This experiment demonstrated the feasibility 
of the rapid noninvasive detection of individual oocyst-
carrying mosquitoes. We propose that vapor nanobubbles 
can be generated around residual hemozoin in developing 
oocysts or similar dense forms of heme formed by the ma-
laria parasites at this stage (32,33).
These results provide a proof-of-principle for the H-
VNB technology as a unique noninvasive transdermal 
diagnostic tool for malarial infection in humans and mos-
quitoes. The next step is to optimize the prototype with 
a malaria-specific laser operating at 672 nm for a better 
sensitivity (22). Such prototype will be evaluated in large-
scale studies in humans in clinical and field settings in ma-
laria-endemic countries. Although the estimated cost of a 
battery-powered device (size of a shoebox) is US $15,000, 
a single unit will be able to test ≈200,000 persons each year 
without any additional cost (e.g., specialized staff, facili-
ties, and diagnostic reagents); thus, the cost of the individ-
ual test may be well below that of a rapid diagnostic test. 
The device may be able to diagnose asymptomatic and low-
density infections, undetectable by microscopy and rapid 
diagnostic tests and could be deployed for mass screening 
and treatment or at border control points (a major advan-
tage would be the speed at which results will be available). 
The presence of hemozoin in all blood stages and types of 
malaria parasites (25,26) ensures the broad and universal 
application of our method, even without differentiation of 
the malaria species. The rapid and simple detection of ma-
laria-infected mosquitoes could provide an easy tool to es-
timate the transmission intensity, contributing to the efforts 
of malaria transmission reduction and local elimination.
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From the Quechua kina, “bark,” quinine is an alkaloid of cinchona that has an-timalarial properties. In the 1620s, Jesuit missionaries living in Peru learned 
of the healing powers of the bark of “fever trees” that grew in the high forests of 
Peru and Bolivia.
“Cinchona	officinalis	001”	by	H.	Zell.	Own	work.	Licensed	under	CC	BY-SA	3.0	via	Wikimedia	Commons.
Quinine [kwinʹin]
